INTRODUCTION: Tuberculosis (TB) is an infectious disease that remains a serious global
public health problem, and lack of adherence to treatment contributes to the development of
resistant strains. OBJECTIVE: To build a web application as a technology to assist in the
management of adverse reactions related to the treatment of MDR TB in patients treated at the
João de Barros Barreto University Hospital (HUJBB). METHODOLOGY: This is a cross sectional, observational, descriptive study on patients diagnosed with multidrug-resistant TB
(MDR TB) in the intensive phase of treatment. In addition, methodological research into
technological development was carried out, which consists of building a product that can be
implemented in the care of patients with MDR TB. The web application was validated by health
professionals who work at the MDR TB Outpatient Clinic and the HUJBB Outpatient Pharmacy
using the form with responses on the Likert scale. RESULTS: In this study, 17 patients were
evaluated, with a predominance of females (52.94%), between 50 and 59 years old (29.41%).
Furthermore, regarding the lifestyle habits of the researched population, it was found that 7
claimed to be alcohol drinkers (33.33%), 5 smokers (23.81%) and 3 illicit drug users (14.29%).
The most predominant clinical complaints were arthralgia, nausea, vomiting and anxiety.
Regarding comorbidities, 60% reported having diabetic mellitus (DM), while the other items,
such as systemic arterial hypertension (SAH), asthma, osteoporosis and neuropathy presented
equal distribution with 10% each. Regarding laboratory tests, the hematimetric parameters of
47.06% of the patients presented anemia, while the biochemical parameters were observed
values above the reference for: fasting glycemia, creatinine, TGO, TGP, alkaline phosphatase,
GAMMA GT, amylase, lipase and in total bilirubin and fractions. Based on this information, a
web application was built and, subsequently, the application was validated using a Likert scale
with health professionals. Thus, a Global Content Validation Index (Global CVI) of 0.93 was
obtained. To be considered valid, the Global CVI must present a value equal to or greater than
0.78. CONCLUSION: The application proved to be valid for use as a tool for managing
complaints related to the treatment of MDR TB.
|
